Director at Universal Insurance (UVE) receives 3,414 restricted shares in equity grant

Rhea-AI Filing Summary

UNIVERSAL INSURANCE HOLDINGS, INC. director Francis Xavier McCahill III received a grant of 3,414 shares of restricted common stock as equity compensation. The award has no cash exercise price and increases his direct holdings to 29,475 shares.

These restricted shares will vest on the earlier of June 11, 2027 or the date of the next annual meeting that occurs at least 50 weeks after the prior year’s annual meeting, aligning the director’s compensation with longer-term company performance and board service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider McCahill Francis Xavier III

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,414	$0.00	--

Holdings After Transaction: Common Stock — 29,475 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted shares granted: 3,414 shares Transaction price per share: $0.0000 Shares held after grant: 29,475 shares +2 more

5 metrics

Restricted shares granted 3,414 shares Equity award of common stock

Transaction price per share $0.0000 Grant, award, or other acquisition

Shares held after grant 29,475 shares Director’s direct ownership after transaction

Vesting date June 11, 2027 Earlier of this date or next qualifying annual meeting

Form type Form 4 Insider grant, award, or other acquisition

Key Terms

restricted shares, vest, annual meeting, grant, award, or other acquisition

4 terms

restricted shares financial

"These restricted shares will vest on the earlier of (i) June 11, 2027"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

vest financial

"These restricted shares will vest on the earlier of (i) June 11, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting regulatory

"the date of the next annual meeting that is at least 50 weeks"

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

grant, award, or other acquisition regulatory

"transaction_code_description: Grant, award, or other acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/12/2026 - 05:52 PM Accepted by SEC EDGAR 06/12/2026 - 05:51 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McCahill Francis Xavier III

(Last) (First) (Middle)

1110 WEST COMMERCIAL BOULEVARD

SUITE 100

(Street)

FORT LAUDERDALE FLORIDA 33309

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL INSURANCE HOLDINGS, INC. [ UVE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		A		3,414(1)	A	$0	29,475	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These restricted shares will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting that is at least 50 weeks after the immediately preceding year's annual meeting.

Remarks:

	/s/ Francis Xavier McCahill III	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Universal Insurance (UVE) report for Francis Xavier McCahill III?

Universal Insurance reported that director Francis Xavier McCahill III received a grant of 3,414 restricted shares of common stock. This is a compensation-related equity award, not an open-market purchase or sale, and increases his direct holdings to 29,475 shares.

How many Universal Insurance (UVE) shares does the director hold after this Form 4 grant?

After the restricted stock grant, director Francis Xavier McCahill III directly holds 29,475 shares of Universal Insurance common stock. This figure reflects his position following the 3,414-share equity award reported in the Form 4 filing.

When do the newly granted UVE restricted shares vest for the director?

The 3,414 restricted shares granted to director Francis Xavier McCahill III vest on the earlier of June 11, 2027, or the date of the next annual meeting held at least 50 weeks after the previous year’s annual meeting, tying vesting to board service timing.

Was there any cash paid for the Universal Insurance (UVE) shares granted to the director?

No cash was paid for the 3,414 Universal Insurance restricted shares granted to director Francis Xavier McCahill III. The transaction price per share is reported as 0.0000, indicating the award is purely equity compensation rather than a market purchase.

Is the UVE Form 4 transaction a buy or sell in the open market?

The Form 4 for Universal Insurance shows an acquisition through a grant or award, not an open-market buy or sell. The transaction is coded as a grant of 3,414 restricted shares, classified as “grant, award, or other acquisition” under the SEC’s reporting codes.